Literature DB >> 8050565

Bilirubin and ascorbate antioxidant activity in neonatal plasma.

V Gopinathan1, N J Miller, A D Milner, C A Rice-Evans.   

Abstract

Extremely low birth weight premature infants have been known for many years to have limited antioxidant protective capacity, especially with reference to those antioxidant components which do not cross the placenta until the third trimester of gestation. In this study the total antioxidant activity and the concentrations of individual antioxidants in plasma from premature neonates (27 +/- 2 weeks gestation) compared to term babies (38-41 weeks gestation) have been examined. The results show elevated levels of ascorbate at birth in the plasma of premature neonates compared with those of term babies, but the total plasma antioxidant status of the premature babies is significantly lower than that of term babies. At 5 days post-partum the ascorbate levels are within the normal adult range and plasma bilirubin levels are considerably enhanced in both groups, while the total plasma antioxidant status of the premature neonates has increased. Analysis of the relationship between the total plasma antioxidant activity and the bilirubin concentration show a direct, highly significant correlation for the term group, r2 = 0.774, consistent with significance of bilirubin as a plasma antioxidant.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050565     DOI: 10.1016/0014-5793(94)00666-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

1.  Changes in serum concentration of antioxidants following treadmill exercise testing in patients with suspected ischaemic heart disease.

Authors:  M E Ashmaig; B J Starkey; A M Ziada; A Amro; S Sobki; G A Ferns
Journal:  Int J Exp Pathol       Date:  2001-08       Impact factor: 1.925

2.  Plasma bilirubin level and oxidative stress in preterm infants.

Authors:  C Dani; E Martelli; G Bertini; M Pezzati; L Filippi; M Rossetti; G Rizzuti; F F Rubaltelli
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

3.  Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants.

Authors:  K Hirano; T Morinobu; H Kim; M Hiroi; R Ban; S Ogawa; H Ogihara; H Tamai; T Ogihara
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

4.  Differential effects of acetaminophen on enzymatic and non-enzymatic antioxidant factors and plasma total antioxidant capacity in developing and adult rats.

Authors:  Abolfazl Dadkhah; Faezeh Fatemi; Somaieh Kazemnejad; Yusef Rasmi; Javad Ashrafi-Helan; Abdolamir Allameh
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 5.  Novel therapies for cyclic GMP control of vascular smooth muscle growth.

Authors:  David A Tulis
Journal:  Am J Ther       Date:  2008 Nov-Dec       Impact factor: 2.688

6.  Iron supplements and oxidative stress in very low birth weight infants.

Authors:  Talkad S Raghuveer; Garry R Buettner
Journal:  J Pediatr       Date:  2008-06       Impact factor: 4.406

7.  Antioxidant properties of blirubin in the model organism, Caenorhabditis elegans.

Authors:  Danny McCaughan; Catherine Au; Alexandre Benedetto; Dejan Milatovic; Judy Aschner; Michael Aschner
Journal:  Int J Neuroprot Neuroregener       Date:  2008

8.  Changes in bilirubin in infants with hypoxic-ischemic encephalopathy.

Authors:  Carlo Dani; Chiara Poggi; Claudia Fancelli; Simone Pratesi
Journal:  Eur J Pediatr       Date:  2018-09-19       Impact factor: 3.183

9.  Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues.

Authors:  S Qanungo; M Mukherjea
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

10.  Antioxidant activity, packed cell transfusions, and outcome in premature infants.

Authors:  K M Silvers; A T Gibson; J M Russell; H J Powers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.